)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company (874) investor relations material
Guangzhou Baiyunshan Pharmaceutical Holdings Company Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary28 Oct, 2026
Executive summary
Q3 2026 operating income RMB19.985bn, +1.08% YoY; total profit RMB581.6m, -46.82%; parent-attributable net profit RMB395.6m, -50.17%.
9M operating income RMB62.076bn, +0.76% YoY; parent-attributable net profit RMB2.492bn, -24.73%; quarterly financial statements unaudited.
Financial highlights
9M total profit RMB3.183bn, down 23.92% YoY; net profit after deducting non-recurring items RMB2.224bn, down 22.50%.
9M net profit RMB2.565bn vs RMB3.398bn YoY; operating profit RMB3.167bn vs RMB4.115bn, while operating costs rose to RMB59.043bn from RMB57.775bn.
9M operating income was RMB62.076bn vs RMB61.606bn; R&D expenses increased to RMB585.7m from RMB443.7m.
Key financial ratios and metrics
9M basic and diluted EPS RMB1.533, down 24.73% YoY; Q3 basic and diluted EPS RMB0.243, down 50.17%.
9M weighted average return on net assets was 6.43%, down 2.45 percentage points YoY.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Guangzhou Baiyunshan Pharmaceutical Holdings Company
- Revenue up 0.61%, net profit down 16.7%, interim dividend of RMB0.30/share proposed.874
Q2 2026 - Operating income rose 3.58% while net profit dipped 2.06% year-over-year in Q1 2026.874Q1 2026
- Net profit rose 5.21% to RMB2.98B on RMB77.66B revenue, focusing on innovation and global expansion.874Q4 2025
- Q3 2025 delivered strong profit growth and EPS, despite a sharp drop in operating cash flow.874Q3 2025
- Revenue up 1.93% YoY, net profit down 1.31%, interim dividend RMB0.40 per share.874Q2 2025
- Net profit fell 37.82% in Q3 2024 as sales and margins declined under macroeconomic pressures.874Q3 2024
- Revenue up 2.68% but net profit down 9.31% amid higher costs and negative cash flow.874Q2 2024
- Revenue and net profit declined in Q1 2025, with cash flow pressures intensifying.874Q1 2025
- Net profit dropped 30% on flat revenue; 2025 focus is on supply chain and innovation.874Q4 2024
Next Guangzhou Baiyunshan Pharmaceutical Holdings Company earnings date
Q4 202617 Mar, 2027
Guangzhou Baiyunshan Pharmaceutical Holdings Company
Next Guangzhou Baiyunshan Pharmaceutical Holdings Company earnings date
Q4 202617 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)